Japan
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
39.99%
|
Dec. 31, 2023 | USD 3.39 | -1.15% |
|
Japan |
|
2 |
29.56%
|
Sept. 30, 2024 | USD 2.93 | -1.24% |
|
Japan |
|
3 |
22.87%
|
March 31, 2024 | USD 16.56 | -1.66% |
|
Japan |
|
4 |
22.59%
|
Dec. 31, 2023 | USD 9.00 | 1.53% |
|
Japan |
|
5 |
21.38%
|
March 31, 2024 | USD 7.13 | 0.05% |
|
Japan |
|
6 |
21.29%
|
June 30, 2024 | USD 8.27 | -1.43% |
|
Japan |
|
7 |
19.99%
|
June 30, 2024 | USD 4.16 | -5.56% |
|
Japan |
|
8 |
19.87%
|
Sept. 30, 2024 | USD 5.44 | 1.95% |
|
Japan |
|
9 |
19.18%
|
March 31, 2024 | USD 10.75 | -2.71% |
|
Japan |
|
10 |
18.92%
|
Feb. 29, 2024 | USD 1.93 | -1.57% |
|
Japan |
|
11 |
18.39%
|
Sept. 30, 2024 | USD 12.61 | -1.89% |
|
Japan |
|
12 |
18.37%
|
Sept. 30, 2024 | USD 3.00 | -0.80% |
|
Japan |
|
13 |
18.10%
|
March 31, 2024 | USD 21.71 | -1.03% |
|
Japan |
|
14 |
17.27%
|
March 31, 2024 | USD 4.22 | 0.95% |
|
Japan |
|
15 |
17.10%
|
March 31, 2024 | USD 3.38 | -1.89% |
|
Japan |
|
16 |
16.73%
|
June 30, 2024 | USD 12.49 | 0.87% |
|
Japan |
|
17 |
16.10%
|
March 31, 2024 | USD 17.01 | -1.22% |
|
Japan |
|
18 |
15.82%
|
Aug. 31, 2024 | USD 9.32 | -2.24% |
|
Japan |
|
19 |
14.71%
|
March 31, 2024 | USD 4.81 | -0.59% |
|
Japan |
|
20 |
14.56%
|
May 31, 2024 | USD 18.25 | -0.97% |
|
Japan |
|
21 |
14.49%
|
Dec. 31, 2023 | USD 5.31 | -1.31% |
|
Japan |
|
22 |
14.23%
|
May 31, 2024 | USD 9.32 | -0.86% |
|
Japan |
|
23 |
13.05%
|
Dec. 31, 2023 | USD 37.30 | -0.84% |
|
Japan |
|
24 |
12.65%
|
Feb. 29, 2024 | USD 17.40 | -0.57% |
|
Japan |
|
25 |
12.46%
|
Feb. 29, 2024 | USD 14.39 | -0.85% |
|
Japan |
|
26 |
12.37%
|
Dec. 31, 2023 | USD 9.78 | -1.94% |
|
Japan |
|
27 |
11.92%
|
March 31, 2024 | USD 13.76 | -1.19% |
|
Japan |
|
28 |
11.36%
|
March 31, 2024 | USD 9.47 | -2.44% |
|
Japan |
|
29 |
11.00%
|
Dec. 31, 2023 | USD 7.76 | -2.37% |
|
Japan |
|
30 |
10.85%
|
March 31, 2024 | USD 13.67 | -2.04% |
|
Japan |
|
31 |
10.39%
|
Dec. 31, 2023 | USD 8.94 | -0.23% |
|
Japan |
|
32 |
10.24%
|
March 31, 2024 | USD 27.69 | -1.34% |
|
Japan |
|
33 |
10.07%
|
March 31, 2024 | USD 18.08 | -2.63% |
|
Japan |
|
34 |
9.68%
|
March 31, 2024 | USD 33.72 | -1.64% |
|
Japan |
|
35 |
9.18%
|
March 31, 2024 | USD 14.21 | 0.00% |
|
Japan |
|
36 |
9.02%
|
March 31, 2024 | USD 15.32 | -0.42% |
|
Japan |
|
37 |
8.76%
|
March 31, 2024 | USD 3.06 | 0.05% |
|
Japan |
|
38 |
8.68%
|
Sept. 30, 2024 | USD 3.52 | 4.58% |
|
Japan |
|
39 |
7.93%
|
March 31, 2024 | USD 25.58 | -1.99% |
|
Japan |
|
40 |
6.84%
|
Aug. 31, 2024 | USD 5.73 | -1.36% |
|
Japan |
|
41 |
6.74%
|
May 31, 2024 | USD 2.15 | -0.59% |
|
Japan |
|
42 |
6.71%
|
June 30, 2024 | USD 5.75 | -2.34% |
|
Japan |
|
43 |
6.10%
|
Sept. 30, 2023 | USD 12.23 | -2.54% |
|
Japan |
|
44 |
5.41%
|
Dec. 31, 2023 | USD 32.47 | -0.78% |
|
Japan |
|
45 |
4.18%
|
March 31, 2024 | USD 23.97 | -0.85% |
|
Japan |
|
46 |
4.09%
|
March 31, 2024 | USD 28.04 | 0.64% |
|
Japan |
|
47 |
4.03%
|
March 31, 2024 | USD 1.99 | 3.78% |
|
Japan |
|
48 |
3.82%
|
Dec. 31, 2023 | USD 2.71 | -1.29% |
|
Japan |
|
49 |
3.15%
|
March 31, 2024 | USD 6.69 | -1.16% |
|
Japan |
|
50 |
3.08%
|
Dec. 31, 2023 | USD 0.81 | 0.21% |
|
Japan |
The Dental Care company in Japan with the highest Return on Capital Employed (ROCE) is Medical Data Vision Co., Ltd. (Tokyo Stock Exchange: 3902.T) at 39.99%.
The Dental Care company in Japan with the lowest Return on Capital Employed (ROCE) is Solasia Pharma K.K. (Tokyo Stock Exchange: 4597.T) at -58.63%.
The top 10 Dental Care companies in Japan by Return on Capital Employed (ROCE) are Medical Data Vision Co., Ltd., Kanamic Network Co.,LTD, IPS, Inc., Recovery International Co.,Ltd., LITALICO Inc., Charm Care Corporation, ASO International, Inc., Nexyz. Group Corporation, SMS Co., Ltd. and Riso Kyoiku Co., Ltd..
The bottom 10 Dental Care companies in Japan by Return on Capital Employed (ROCE) are Solasia Pharma K.K., Data Horizon Corporation, Soiken Holdings Inc., H.U. Group Holdings, Inc., PHC Holdings Corporation, Wakamoto Pharmaceutical Co.,Ltd., Seikagaku Corporation, Artra Group Corporation, Renaissance,Incorporated and teno. Holdings Company Limited.